CollPlant Biotechnologies Ltd (CLGN) stock
Close on Nov 11, 2026Market cap –P/E –Yield –
CollPlant Biotechnologies statistics
40 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- 6.54%
- 3.32%
- Shares Held by Institutions
- 0.00%
- 60.5%
MarginsIndustry
- EBITDA Margin
- -445.8%
- -2.52%
- FCF Margin
- -398.4%
- 0.65%
Returns on capitalIndustry
- Return on Equity (ROE)
- -148.7%
- -17.3%
- Return on Assets (ROA)
- -93.3%
- -12.3%
- Return on Invested Capital (ROIC)
- -1245.2%
- -2.83%
- Return on Capital Employed (ROCE)
- -243.7%
- -8.13%
Financial positionIndustry
- Current Ratio
- 1.57
- 2.49
- Quick Ratio
- 1.04
- 1.53
GrowthIndustry
- Revenue Growth (YoY)
- 360.4%
- 9.42%
- Revenue Growth (3Y CAGR)
- 99.4%
- 7.08%
- Revenue Growth (5Y CAGR)
- -17.3%
- 11.8%
EfficiencyIndustry
- Asset Turnover
- 0.19
- 0.59
- Inventory Turnover
- 1.53
- 2.20
- Revenue Per Employee
- $60.79K
- $331.99K
- Profits Per Employee
- -$294.59K
- -$46.47K
- Employee Count
- 39
- 193
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $2.56M
- $3.95M
- Net Cash Per Share
- $1.77
- $0.26
- Equity (Book Value)
- $2.95M
- $63.80M
- Book Value Per Share
- $2.04
- $3.26
- Tangible Book Value
- $2.90M
- $11.61M
- Working Capital
- $1.41M
- $57.32M
Cash flow (TTM)Industry
- Capital Expenditures
- -$28.00K
- -$3.94M
- FCF Per Share
- -$6.54
- -$0.00
Scores and fair valueIndustry
- Piotroski F-Score
- 3
- 5
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | CLGN | S&P 500 | Difference | CLGN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +12.8% | -2.4% | +15.2 pts | ||
| 3 months | +34.2% | -1.2% | +35.4 pts | ||
| Year to date | -71.7% | +12.3% | −84.0 pts | ||
| 1 year | -79.2% | +12.4% | −91.6 pts | ||
| 3 years | -93.0% | +78.8% | −171.8 pts | -58.7% | +21.4% |
| 5 years | -98.1% | +75.2% | −173.3 pts | -54.9% | +11.9% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M CLGN shares were sold short on Oct 30, 2026, down 32.5% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 27.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 35,612 | -32.5% | 34,576 | 1.0 |
| Oct 15, 2026 | 52,732 | +24.9% | 55,299 | 1.0 |
| Sep 30, 2026 | 42,221 | -19.2% | 78,372 | 1.0 |
| Sep 15, 2026 | 52,237 | -60.2% | 211,002 | 1.0 |
| Aug 31, 2026 | 131,118 | +498.5% | 17,402,039 | 1.0 |
| Aug 14, 2026 | 21,907 | +45.8% | 101,453 | 1.0 |
| Jul 31, 2026 | 15,029 | -7.5% | 21,352 | 1.0 |
| Jul 15, 2026 | 16,240 | -51.8% | 29,266 | 1.0 |
| Jun 30, 2026 | 33,721 | +59.5% | 53,821 | 1.0 |
| Jun 15, 2026 | 21,144 | -50.2% | 112,211 | 1.0 |
| May 29, 2026 | 42,484 | -49.6% | 38,729 | 1.1 |
| May 15, 2026 | 84,316 | +4.8% | 38,460 | 2.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?